The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Testing HIV positive was the beginning of Margaret Mbabazi’s anguish. It never crossed her mind that her husband and the father of her four children could chase her away from their marital home. But when he tested HIV negative that is exactly what happened.
Ndaula Hamidu, 24, was born with HIV and is now an advocate for sexual and reproductive rights and services, including family planning – issues he says concern young men as well as young women.
HIV transmission from mother-to-child (MTCT) in South Africa fell to just 1.5% in 2015.
Strong rights-based approach needed to end AIDS, but new UNAIDS stratergy makes only fleeting reference to female genital mutilation and child marriage
Company-provided antiretroviral treatment (ART) programmes are found to be highly cost-effective in settings with a high HIV prevalence.
Two major studies presented at the recent International AIDS Conference in Vancouver highlight the importance of peer and community interventions in improving outcomes for mothers living with HIV. Support to ensure timely access to prevention of mother to child transmission (PMTCT) services and encouragement to stay in care are central to this.
South Africa has undertaken the largest ever national stigma survey involving 10,500 people living with HIV. The Stigma Index Survey revealed that although South Africa has much lower levels of HIV stigma than other African countries, women continue to be disproportionately affected, particularly in relation to sexual and reproductive health.
Francis Chimenya, citizen journalist from the Key Correspondents network
Two studies involving women in South Africa, Malawi, Uganda, Rwanda and Zimbabwe are exploring the use of a vaginal ring that delivers antiretroviral drugs, to see if it can prevent transmission of HIV.
The Ring Study is a clinical study by the International Partnership for Microbicides (IPM) and its sister study ASPIRE is being led by Microbicide Trial Network (MTN). Both studies began in June 2012 with about 4,580 women aged 18-45 in 22 sites across Africa.
Woman who take daily pre-exposure prophylaxis (PrEP) adhere significantly better than woman who take PrEP only twice a week, or before and after sex, as suggested by findings from the HIV Prevention Trials Network (HPTN) 067 trial.
A recently published study about the failure of the Vaginal and Oral Interventions to Control the Epidemic (VOICE) trial in the New England Journal of Medicine, argues that the negative outcome of the study was not associated with the non-effectiveness of the product, but the participants deceit and lack of compliance. The VOICE trial was abruptly stopped after independent safety monitors concluded that the women who were given the pills and vaginal gels containing antiretrovirals (ARVs) were becoming infected at the same rate as women who were given a placebo.